KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVS) Other Non-Current Liabilities (2017 - 2025)

Novartis Ag's Other Non-Current Liabilities history spans 9 years, with the latest figure at $4.1 billion for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 704.09% year-over-year to $4.1 billion; the TTM value through Dec 2025 reached $4.1 billion, up 704.09%, while the annual FY2025 figure was $4.1 billion, 704.09% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $4.1 billion at Novartis Ag, up from $514.0 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $6.2 billion in Q4 2021 and bottomed at $514.0 million in Q4 2024.
  • The 5-year median for Other Non-Current Liabilities is $4.1 billion (2025), against an average of $3.3 billion.
  • The largest annual shift saw Other Non-Current Liabilities skyrocketed 1409.05% in 2021 before it crashed 83.61% in 2023.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $6.2 billion in 2021, then dropped by 20.51% to $4.9 billion in 2022, then plummeted by 83.61% to $804.0 million in 2023, then plummeted by 36.07% to $514.0 million in 2024, then surged by 704.09% to $4.1 billion in 2025.
  • Per Business Quant, the three most recent readings for NVS's Other Non-Current Liabilities are $4.1 billion (Q4 2025), $514.0 million (Q4 2024), and $804.0 million (Q4 2023).